The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Agree Safy that revenue will be a key focus notwithstanding all the great products TILS has at various stages so based on forward potential. That’s why I curious about the year end, which feels like it has to be next week.
I personally don’t think we’ll hear about the StemprintER spin off for some time yet due to all the work involved. If they actually do it as it’s not guaranteed.
Agree that a danger that some people could possibly move some holdings into some others companies with all the positive action last week.
Why would you need a placing when you have ATM facility and are fully funded. Furthermore company have said thet Stem is not jewel in crown, they could sell stem and easily bring in excess of $1 billion. Regardless the £1 resistance has been impossible to break and this is a long term hold.
Don't agree about a placing. Why would they need one when they can keep drawing on the $20m block listing as and when they need?
The StemPrintER split Date can’t come quick enough for me And would stop the one or two negative slants towards the company, if you have done your dd then the noise shouldn’t affect your judgement on tils future.
I’m really hope the split RNS comes next week with detail of which way they would like to take the StemPrintER project a joint venture or a sale, maybe I’m asking too much in these early days but you never know.
Safy I agree we have a few million knocking around so no placing short term imo.
Ps RNs mon would make a few have a wobble :-)
We thought avct was fully funded! The begging bowl is alqays out at aim companies!
But like at avct a placing dosent have to be bad.
It will come good here but its hard to say when.
Im happy with my holding at the moment,should this drop to 80p with no news i may add more depending on how my others are doing.
The blue chips across uk ,europe and usa are on a crazy rally at the moment,imo well over done,untill more certainty on covid and the porential 2nd wave.
If the 2nd wave does come in the winter there could be big problems.
Also think it’s a bit more complicated to say a placing might come.
They are fully funded at the moment.
If they plan to do something for Stem then they could do that post StemprintER newco. If it even gets that far.
Which doesn’t impact Tils Sp.
Seems like he has moved on.
Think as you say people want to see an RNS with revenue being main focus.
Something saying what they value Stem at, if they are talking to people, what they intend to do with it, sell or keep to generate revenue. All very important going forwards.
where has invest gone??
Has he sold ,after his continuous pumping??
I did say a week or 2 ago it would range between 90-110 (if i remember correctly).
We are going to need big news to get us out of that range,and the big news will need to contain some revenue!
I am still of the opinion a placing will come 1st (wich is not always a bad thing if its used in a good way)